Greenebaum Cancer Center - Clinical Trials

  Clinical Trials...
     More About Clinical Trials
     Participating
     Questions to Ask
     For More Information
  Research
  Cancer Overviews
  Treatment Programs
  Physicians and Staff

Current Clinical Trials for Other

GCC 0853 - GCC 0853: A single-arm, open-label study of the Palatability and Tolerability of Exjade Taken with Meals, with Different Liquids or Crushed and Added to Food

GCC0659 - Phase II Trial of Sunitinib (SU11248) In Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers And Medullary Thyroid Cancers (NCI # 7735)

GCC0910 - A Randomized, Double-blind, Placebo-controlled Study of the JAK Inhibitor INCB018424 Tablets Administered Orally to Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera- Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia-Myelofibrosis (PET-MF)



Email this Page                                                                     Print this Page

Home Site Map Disclaimer University of Maryland Greenebaum Cancer Center UM School of Medicine UM Medical System UM Medical Center Text: If you would like to make an appointment or talk to someone about our services please call 1-800-888-8823. Physicians can call our dedicated consultation referral service at 1-800-373-4111.